Clinical trial
ANTIPLATELET TREATMENT IN ACUTE CORONARY SYNDROMES. SAFETY AND EFFICACY OF ANTIPLATELET SWITCHING Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome
NCT04630288 is registered in ClinicalTrials.gov with Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ANTIPLATELET TREATMENT IN ACUTE CORONARY SYNDROMES. SAFETY AND EFFICACY OF ANTIPLATELET SWITCHING Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome
- Lead sponsor
- Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 2, 2019
- Completion date
- December 31, 2020
- Enrollment
- 1,900 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndromes